Skip to main content

Table 2 Stratified prevalence of lifetime, current, and past CAM use, and of willingness to try CAM

From: Complementary and alternative medicine use in adults with autism spectrum disorder in Germany: results from a multi-center survey

  

Prevalence in % (95% CI)

 
 

lifetime usea

current use

past use

willingness to tryb

Sex

    

 Male

43.8 (35.8–52.0)

27.5 (20.6–35.2)

24.2 (17.6–31.8)

20.3 (14.2–27.5)

 Female

48.7 (32.4–65.2)

33.3 (19.1–50.2)

25.6 (13.0–42.1)

17.9 (7.5–33.5)

Age groups (in years)

    

 18–24

44.1 (31.2–57.6)

20.3 (11.0–32.8)

32.2 (20.6–45.6)

10.2 (3.8–20.8)

 25–34

40.3 (28.9–52.5)

30.6 (20.2–42.5)

18.1 (10.0–28.9)

20.8 (12.2–32.0)

  ≥ 35

50.8 (37.7–63.9)

34.4 (22.7–47.7)

24.6 (14.5–37.3)

27.9 (17.1–40.8)

Diagnoses

    

 Other ASD diagnosis

42.0 (31.1–53.5)

28.4 (18.9–39.5)

22.2 (13.7–32.8)

21.0 (12.7–31.5)

 Asperger syndrome

46.8 (37.3–56.6)

28.8 (20.6–38.2)

26.1 (18.2–35.3)

18.9 (12.1–27.5)

Intellectual functioning

    

 IQ < 85

42.6 (29.2–56.8)

31.5 (19.5–45.6)

25.9 (15.0–39.7)

16.7 (7.9–29.3)

 IQ ≥ 85

42.7 (33.9–51.9)

27.4 (19.8–36.2)

21.0 (14.2–29.2)

21.0 (14.2–29.2)

Level of education

    

 Low

44.6 (31.3–58.5)

32.1 (20.3–46.0)

25.0 (14.4–38.4)

17.9 (8.9–30.4)

 Medium

41.2 (27.6–55.8)

23.5 (12.8–37.5)

27.5 (15.9–41.7)

9.8 (3.3–21.4)

 High

47.1 (36.1–58.2)

29.4 (20.0–40.3)

22.4 (14.0–32.7)

27.1 (18.0–37.8)

 Overall

44.8 (37.6–52.1)

28.6 (22.4–35.6)

24.5 (18.6–31.2)

19.8 (14.4–26.1)

  1. acontains all respondents who stated current use, past use or both
  2. bcontains also respondents who stated that they already use or have used some other CAM modality